Asymmetric allylboration for the synthesis of β-hydroxy-δ-lactone unit of statin drug analogs

Journal of Organometallic Chemistry

Volumn 624, Issue 1-2, 2001, Pages 239-243

  Reddy, M Venkat Ram ^a   Brown, Herbert C ^a   Ramachandran, P Veeraraghavan ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Allylboration; Asymmetric synthesis; Epoxidation; Metathesis; Reduction

Indexed keywords

EID: 0001514115     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-328X(01)00665-9     Document Type: Article

References (72)

1. A. Endo, M. Kuroda, Y. Tsujita, J. Antibiot. 29 (1976) 1346.
2. A.G. Brown, T.C. Smale, T.J. King, R. Hasenkamp, R.H. Thompson, J. Chem. Soc. Perkin Trans. I (1976) 1165.
3. (a) A.W. Alberts, T.C. Smale, Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 3957.
4. (b) P.R. Hebert, J.M. Gaziano, K.S. Chan, C.H. Hennekens, JAMA 278 (1997) 4.
5. (c) http://www.pharminfo.com/ pubs/msb/statins.html.
6. Mevacor® is a trademark of Merck & Co.
7. Launched in the market (Merck & Co.) in 1988. FDA approved new dose ranges for Zocor® in 1998.
8. Pravachol is a trademark of Bristol-Myers Squibb. FDA approved in 1996.
9. FDA approved in 1996, Lipitor® is a trademark of Pfizer (Parke-Davis).
10. Launched in the market in 1995. Baycol® is a trademark of Bayer in the USA.
11. Lescol is a trademark of Novartis Pharma AG.
12. Statin drugs constituted ∼ 6% of the total annual sale of the top 200 drugs in 1999, worth $125 billion in the USA. Lipitor, $3.0b; Zocor, $2.3b; Pravacol, $1.18b; Mevacor, $389.5m; and Lescol, $268.1m. For a listing of the top 200 prescription drugs, see: http://www.rxlist.com and a listing of the top 200 drugs in sales, see: http://www.pharmacyline.com.
13. Statin drugs constituted ∼ 6% of the total annual sale of the top 200 drugs in 1999, worth $125 billion in the USA. Lipitor, $3.0b; Zocor, $2.3b; Pravacol, $1.18b; Mevacor, $389.5m; and Lescol, $268.1m. For a listing of the top 200 prescription drugs, see: http://www.rxlist.com and a listing of the top 200 drugs in sales, see: http://www.pharmacyline.com.
14. (a) S.Y. Sit, R.A. Parker, I. Motoc, W. Han, N. Balasubramanian, J.D. Catt, P.J. Brown, W.E. Harte, M.D. Thompson, J.J. Wright, J. Med. Chem. 33 (1990) 2982.
15. (b) G.E Stokker, W.F. Hoffman, A.W. Alberts, E.J. Cragoe Jr, A.A. Deana, J.L. Gilfillan, J.W. Huff, F.C. Novello, J.D. Purgh, R.L Smith, A.K. Willard, J. Med. Chem. 28 (1985) 347.
16. (a) T. Honda, S. Ono, H. Mizutani, K.O. Hallinan, Tetrahedron Asymm. 8 (1997) 181.
17. (b) M. Majewski, D.L.J. Clive, P.C. Anderson, Tetrahedron Lett. 25 (1984) 2101.
18. (c) C. Bonini, R. Racioppi, L. Viggiani, G. Righi, L. Rossi, Tetrahedron: Asymm. 4 (1993) 793.
19. (d) C. Bonini, R. Racioppi, G. Righi, L. Viggiani, J. Org. Chem. 58 (1993) 802.
20. (d) B.D. Roth, W.H. Roark, Tetrahedron Lett. 29 (1988) 1255.
21. (e) Y.L. Yang, J.R. Flack, Tetrahedron Lett. 23 (1982) 4305.
22. (f) A.D. Mico, G. Piancatelli, S. Cacurri, S. Lappa, Gazz. Chim. Ital. 122 (1992) 415.
23. (g) S.D. Rychnovsky, G. Griesgraber, S. Zeller, D.J. Skalitzky, J. Org. Chem. 56 (1991) 5161.
24. (h) C.R. Johnson, C.H. Senanayake, J. Org. Chem. 54 (1989) 736.
25. (i) F. Bonadies, R.D. Fabio, A. Gubbiotti, S. Melozzi, C. Bonini, Tetrahedron Lett. 28 (1987) 703.
26. (j) G. Solladie, C. Bauder, L. Rossi, J. Org. Chem. 60 (1995) 7774.
27. (k) V. Yadav, K.K. Kapoor, Ind. J. Chem. Sect. B. 34 (1995) 1026.
28. (a) S. Takano, T. Kamikubo, T. Sugihara, K. Ogasawara, Tetrahedron Asymm. 3 (1992) 853.
29. (b) H. Urabe, T. Matsuka, F. Sato, Tetrahedron Lett. 33 (1992) 4183.
30. (c) T. Hiyama, G.B. Reddy, T. Minami, T. Hanamoto, Bull. Chem. Soc. Jpn. 68 (1995) 350.
31. (d) T. Hiyama, T. Minami, K. Takahashi, Bull. Chem. Soc. Jpn. 68 (1995) 364.
32. (e) B. Henkel, A. Kunath, H. Schick, Tetrahedron: Asymm. 4 (1993) 153.
33. (f) B. Henkel, A. Kunath, H. Schick, Liebigs Ann. Chem. (1992) 809.
34. (g) F. Bennet, D.W. Knight, Tetrahedron Lett. 29 (1988) 4625.
35. (h) F. Bonadies, R.D. Fabio, A. Gubbiotti, S. Mecozzi, C. Bonini, Tetrahedron Lett. 28 (1987) 703.
36. (i) K. Prasad, R. Oljan, Tetrahedron Lett. 25 (1984) 2435.
37. (j) M. Sato, S. Sunami, Y. Sugita, C. Kaneko, Chem. Pharm. Bull. 42 (1994) 839.
38. (k) G.B. Reddy, T. Minami, T. Hanamoto, T. Hiyama, J. Org. Chem. 56 (1991) 5752.
39. (l) B. O'Connor, G. Just, Tetrahedron Lett. 27 (1986), 5201.
40. (m) K. Prasad, O. Repic, Tetrahedron Lett. 25 (1984) 2435.
41. (n) W.F. Hoffman, A.W. Alberts, E.J. Cragoe Jr, A.A. Deana, B.E. Evans, J.C. Gifillan, N.P. Gould, J.W. Huff, F.C. Novello, J.D. Prugh, K.E. Rittle, R.I. Smith, G.E. Stokker, A.K. Willard, J. Med. Chem. 29 (1986) 159.
42. (a) R. Ballini, E. Marcantoni, M. Petrini, J. Chem. Soc. Perkin Trans I (1991) 490.
43. (b) S. Takano, Y. Shimazaki, Y. Sekiguchi, K. Ogasawara, Synthesis (1989) 539.
44. (c) J.M. Escudier, M. Baltas, L. Gorrichon, Tetrahedron Lett. 32 (1991) 5345.
45. (d) J.M. Escudier, M. Baltas, L. Gorrichon, Tetrahedron 49 (1993) 5253.
46. (e) S. Hatakeyama, K. Satoh, S. Takano, Tetrahedron Lett. 34 (1993) 7425.
47. (f) M. Oizumi, M. Takahashi, K. Ogasiwara, Synlett 9 (1997) 1111.
48. (g) S. Schabbert, R. Tiedemann, E. Schaumann, Liebigs Ann. Reel. (1977) 879.
49. (h) G. Dujardin, S. Rossignol, E. Brown, Synthesis (1998), 763.
50. (i) M. Miyazawa, E. Matsuoka, S. Sasaki, S. Oonuma, K. Maruyama, M. Miyashita, Chem Lett. (1998) 109.
51. (j) K. Prasad, O. Repic, Tetrahedron Lett. 25 (1984) 3391.
52. (k) A.K. Ghosh, H. Lei, J. Org. Chem. 65 (2000) 4779.
53. (a) K. Narasaka, F.C. Pai, Tetrahedron 40 (1984) 2233.
54. (b) K.M. Chen, G.E. Hardmann, K. Prasad, O. Repic, M.J. Shapiro, Tetrahedron Lett. 28 (1987) 155.
55. (a) P.V. Ramachandran, M.V.R. Reddy, H.C. Brown, Tetrahedron Lett. 41 (2000) 853.
56. (b) P.V. Ramachandran, M.V.R. Reddy, H.C. Brown, J. Ind. Chem. Soc. 75 (1999) 789.
57. H.C. Brown, P.K. Jadhav, J. Am. Chem. Soc. 105 (1983) 2092.
58. 1H-NMR spectroscopy.
59. Chiralcel® OD-H™ is a product of Chiral Technologies, Inc. Exton, PA.
60. R.H. Grubbs, S. Chang, Tetrahedron 54 (1998) 4413.
61. (b) Wright, D.L. Current Org. Chem. 3 (1999) 211 and references cited therein.
62. M. Miyashita, T. Suzuki, M. Hoshino, A. Yoshikoshi, Tetrahedron 53 (1997) 12469.
63. (a) H.C. Brown, K.S. Bhat, J. Am. Chem. Soc. 108 (1986) 5919.
64. (b) H.C. Brown, P.K. Jadhav, P.T. Perumal, Tetrahedron Lett. 25 (1984) 5111.
65. (c) H.C. Brown, P.K. Jadhav, Tetrahedron Lett. 25 (1984) 1215.
66. (d) H.C. Brown, R.S. Randad, Tetrahedron 46 (1990) 4463.
67. (e) H.C. Brown, P.K. Jadhav, K.S. Bhat, J. Am. Chem. Soc. 110 (1988) 1535.
68. (f) H.C. Brown, G. Narla, J. Org. Chem. 60 (1995) 4686.
69. (g) H.C. Brown, P.K. Jadhav, K.S. Bhat, J. Am. Chem. Soc. 107 (1985) 2564.
70. (h) A.G.M. Barrett, M.A. Seefeld, Tetrahedron 49 (1993) 7857.
71. (i) S. Hu, S. Jayaraman, A.C. Oehlschlager, J. Org. Chem. 61 (1996) 7513.
72. H.C. Brown, G.W. Kramer, A.B. Levy, M.M. Midland, Organic Syntheses via Boranes, Wiley-Interscience, New York, 1975 Reprinted edition, vol. 1. Aldrich Chemical Co. Inc., Milwaukee, WI, 1997, Chapter 9.